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Given the severity and scope of the current COVID-19 pandemic, it is critical to determine
predictive features of COVID-19 mortality and medical resource usage to effectively inform
health, risk-based physical distancing, and work accommodation policies. Non-clinical
sociodemographic features are important explanatory variables of COVID-19 outcomes,
revealing existing disparities in large health care systems.
Methods and findings
We use nation-wide multicenter data of COVID-19 patients in Brazil to predict mortality and
ventilator usage. The dataset contains hospitalized patients who tested positive for COVID-
19 and had either recovered or were deceased between March 1 and June 30, 2020. A total
of 113,214 patients with 50,387 deceased, were included. Both interpretable (sparse ver-
sions of Logistic Regression and Support Vector Machines) and state-of-the-art non-inter-
pretable (Gradient Boosted Decision Trees and Random Forest) classification methods are
employed. Death from COVID-19 was strongly associated with demographics, socioeco-
nomic factors, and comorbidities. Variables highly predictive of mortality included geo-
graphic location of the hospital (OR = 2.2 for Northeast region, OR = 2.1 for North region);
renal (OR = 2.0) and liver (OR = 1.7) chronic disease; immunosuppression (OR = 1.7); obe-
sity (OR = 1.7); neurological (OR = 1.6), cardiovascular (OR = 1.5), and hematologic (OR =
1.2) disease; diabetes (OR = 1.4); chronic pneumopathy (OR = 1.4); immunosuppression
(OR = 1.3); respiratory symptoms, ranging from respiratory discomfort (OR = 1.4) and dys-
pnea (OR = 1.3) to oxygen saturation less than 95% (OR = 1.7); hospitalization in a public
hospital (OR = 1.2); and self-reported patient illiteracy (OR = 1.1). Validation accuracies
(AUC) for predicting mortality and ventilation need reach 79% and 70%, respectively, when
using only pre-admission variables. Models that use post-admission disease progression
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information reach accuracies (AUC) of 86% and 87% for predicting mortality and ventilation
use, respectively.
Conclusions
The results highlight the predictive power of socioeconomic information in assessing
COVID-19 mortality and medical resource allocation, and shed light on existing disparities in
the Brazilian health care system during the COVID-19 pandemic.
Introduction
We are experiencing a devastating global pandemic due to SARS-CoV-2, a highly infectious
pathogen that causes COVID-19. Following the appearance of the first COVID-19 cases in the
province of Hubei, China, in December 2019 [1], SARS-CoV-2 has infected most of the coun-
tries in the world, with over 26.6 million confirmed cases, and just under 876,000 deaths as of
September 5, 2020 [2].
Several studies have identified comorbidities and clinical variables associated with higher
risk of hospitalization and mortality due to COVID-19 [3–15]. Increasing evidence shows that
patients with pre-existing conditions such as diabetes, lung and renal diseases, hypertension,
and older age are especially at risk of succumbing to this viral infection. Additional reports
have pointed to racial and ethnic differences in outcomes [16–18]. In New York City, death
rates among black/African American COVID-19 patients (92.3 deaths per 100,000 population)
and Hispanic/Latino (74.3) have been significantly higher than those of white (42.5) or Asian
(34.5) patients [19]. In addition, an analysis of the largest integrated-delivery health system in
the state of Louisiana suggested a longer wait to access care among black patients [17].
Although racial and ethnic disparities have emerged as a central topic in the conversation
about COVID-19, most studies to date have assessed data from minority populations within
the United States. Moreover, because data on socioeconomic status are seldom available in
electronic medical record systems, the connection between socioeconomic/racial/ethnic dis-
parities and health access inequality has yet to be investigated. It is clear, therefore, that further
research on the underlying causes of COVID-19 disparities and their complex social and struc-
tural determinants is needed in order for the international scientific, public health, and clinical
communities to implement interventions that alleviate excess mortality and economic disrup-
tion related to COVID-19. Because targeted public health and resource allocation policies are
more effective than standard approaches [20], the design of such interventions should leverage
patient subgroup-specific information, such as race/ethnicity and socioeconomic status, and
be adapted to local contexts and community characteristics.
In particular, factors that differentiate underserved populations may be geographically dis-
tinct, meaning that findings from recent U.S.-based studies may generalize poorly to low- and
middle- income countries located, e.g., in Africa or Latin America. Underserved populations
in urban settings in these countries typically live in more densely populated areas, both by
neighborhood and household assessments; rely mainly or exclusively on crowded public trans-
portation to get around; tend to be employed in public-facing occupations; and have limited
access to private health insurance.
Our goal is to contribute to the discussion on COVID-19 disparities by assessing the role of
socioeconomic factors in predicting patient outcomes in Brazil, a low- and middle- income
country (LMIC). At the time of this report, Brazil presented the second highest number of
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total confirmed cases and deaths worldwide [2]. We use a highly representative dataset of
COVID-19 patients from Brazil to derive machine learning models that predict in-hospital
death and ventilator usage. To the best of our knowledge, this is the first study to evaluate the
effect of non-clinical factors, including patients’ self-reported race and education level, access
to private hospitals, and geographic location of the hospital, on COVID-19 mortality and
resource use. Moreover, this is one of the largest datasets used to date, with over 159,000 hospi-
talized COVID-19 patients, including 54,000 deceased.
To develop the predictive models, we leverage both interpretable machine learning (ML)
methods and others which form ensembles of a large number of decision trees and, thus,
are not easy to interpret. We find that the simpler interpretable models, coupled with opti-
mized feature selection, perform just as well as the complex non-interpretable models. This
contributes to the discussion on using interpretable ML models for high-stake decision-
making [21, 22].
Data
The first confirmed COVID-19 case in Brazil was reported on February 26, 2020 in the state of
São Paulo [23, 24]. Starting in March 2020, control measures were implemented in the country
in a decentralized manner, with each state being responsible for the adoption and enforcement
of its own set of social distancing measures. The states of São Paulo and Rio de Janeiro were
the first to shut down non-essential services, including shopping and fitness centers, and to
cancel all public events [25]. At the time of this report, just over six months after confirmation
of the first case, the total number of cases in Brazil surpassed the 4 million mark, with over
125,500 deaths [1], albeit with an estimated reporting rate of only 9.2% [26].
In 2009, the Brazilian Ministry of Health established a nationwide surveilance program for
acute respiratory distress syndrome (ARDS) following the H1N1 Influenza outbreak. The pro-
gram maintains a publicly available database repository [27] in which all health care institu-
tions must report confirmed ARDS cases. For reporting purposes, Influenza patients are
classified as those who present fever or a fever sensation accompanied by one or more of the
following symptoms: cough, sore throat, dripping nose, difficulty breathing, and nose running
down throat. If the condition of a flu patient develops into one or more of the symptoms
below, they are classified as ARDS: dyspnea/respiratory distress, persistent chest pressure, oxy-
gen saturation less than 95% in ambient air, bluish color of the lips or face.
In 2020, the ARDS program was extended to include COVID-19 surveillance. Data used in
this study was extracted from the ARDS surveillance database repository (accessed on July 2,
2020), and included information on demographic characteristics, symptoms and comorbidi-
ties, resource usage, x-ray thorax results, and COVID-19 outcome (recovered, deceased, ongo-
ing). Because our goal is to generate predictive models for mortality and ventilation need, we
filtered the dataset and retained only cases pertaining to hospitalized patients who tested posi-
tive for COVID-19 and had either recovered or were deceased between March 1 and June 30,
2020. We removed outliers in the dataset which are easily identified, for example, repeated
rows, empty entries, and the pregnancy of male patients. After this cleaning process, the num-
ber of patients left was 113,314 including 50,387 deceased. A description of the patient features
in the dataset with corresponding counts is provided in Table 1. Note that the sum of the cate-
gories of a variable may not total 100%, e.g., in the Race variable. This means that the rest of
the observations have unknown values for this variable. In addition to Table 1, Fig 1 shows the
fraction of deceased patients across different characteristics and age groups, e.g., in the upper-
right box, 0.7 is the ratio of deceased patients who are 65–100 years old and have ARDS over
the total number of 65–100 years old patients with ARDS (deceased or not).
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Table 1. Patient characteristics in the dataset reported as: Count (percentage).
Demographics Gender Female 49184 (43.4%)
Other 32 (0.0%)
Male 63998 (56.5%)




Schooling No Education 2799 (2.5%)
Elem 1-5 9374 (8.3%)
Elem 6-9 6727 (5.9%)
Medium 1-3 12629 (11.2%)
Superior 6572 (5.8%)













Respiratory Discomfort 64854 (57.3%)
SpO2 less 95% 62908 (55.6%)
Diarrhea 15493 (13.7%)
Vomiting 8753 (7.7%)
Other Symptoms 37791 (33.4%)
Prior Medical Conditions Postpartum 387 (0.3%)
Cardiovascular Disease 37392 (33.0%)
Hematologic Disease 1052 (0.9%)
Down Syndrome 298 (0.3%)
Liver Chronic Disease 1068 (0.9%)
Asthma 3046 (2.7%)
Diabetes 29120 (25.7%)
Neurological Disease 4516 (4.0%)
Another Chronic Pneumopathy 4281 (3.8%)
Immunosuppression 3455 (3.1%)
Renal Chronic Disease 4945 (4.4%)
Obesity 4186 (3.7%)
Other Risks 30105 (26.6%)
COVID-19 related Resources Antiviral Use 33785 (29.8%)
ICU 35675 (31.5%)
Ventilator Invasive 22571 (19.9%)
(Continued)
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Methods
The study analyzed publicly available data that have been fully de-identified, so additional ethi-
cal approval was not required. The primary objective in learning a classifier is to maximize pre-
diction accuracy (or minimize a loss function). In light of the discussion on favoring
interpretable models, we will examine our models from two aspects: prediction performance
and interpretability.
Classifiers
We are interested in defining two prediction tasks, mortality and the need for mechanical ven-
tilation. For each task, we build five classifiers using Logistic Regression (LR), sparse versions
of LR and Support Vector Machines (SVM), Random Forests [28], and Gradient Boosted
Trees (XGBoost [29]). We choose to construct the SVM and LR classifiers given their ability to
provide quantifiable associations with specific variables driving the predictions, which is criti-
cal in our setting. Conversely, we use state-of-the-art algorithms: Random Forests and
XGBoost, to compare their performance with LR and SVM. A brief discussion of these meth-
ods is provided in the S1 File.
Evidence has shown that sparse classifiers, i.e., the ones which use a parsimonious set fea-
tures, offer higher interpretability and they perform better out of sample [30]. To that end, we
develop a fully automated pre-processing procedure to select a smaller subset of variables to be
used in the classification task. The steps we employ are as follows.
Pre-processing and feature selection
First, we (i) remove unknown or missing entries: After performing one-hot encoding for cate-
gorical features, we discard all the new variables corresponding to unknown or missing entries,
given that these do not add any new information to our predictive task and harm interpretabil-
ity. Then, we (ii) remove correlated variables to avoid collinearity. In particular, we calculate
pairwise correlations among variables, and remove one variable from each highly correlated
pair (those with an absolute correlation coefficient greater than 0.8). Next, we (iii) remove low
influence variables: we separate observations in two classes, the positive (e.g., deceased, or ven-
tilated) and the negative class. Then, for each feature we test whether the two cohorts have the
same mean by performing a two-sided t-test. To keep the variables with the higher impact, we
retain the ones for which we have a 95% confidence that the mean for the two samples is differ-
ent. Finally, we perform (iv) Cross-Validated Recursive Feature Elimination [31]: this
Table 1. (Continued)
Xray Thorax Result Normal 2892 (2.6%)




Outcome Recovered 62827 (55.5%)
Deceased 50387 (44.5%)
Hospital Public 22745 (20.1%)
Private 28041 (24.8%)
Other Acute Respiratory Distress Syndrome 28496 (25.2%)
Contracted At Hospital 2687 (2.4%)
https://doi.org/10.1371/journal.pone.0240346.t001
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Fig 1. Fraction of deceased patients given a certain feature and age group.
https://doi.org/10.1371/journal.pone.0240346.g001
PLOS ONE Physiological and socioeconomic characteristics predict COVID-19 outcomes in Brazil
PLOS ONE | https://doi.org/10.1371/journal.pone.0240346 October 14, 2020 6 / 15
procedure begins by learning a classifier (we use LR) using all features and computing an
importance score. For LR, the importance score is the (absolute) magnitude of the linear coef-
ficient βi of feature i. After this step, the least important feature (the one with the smallest |βi|)
is deleted, and this process is repeated iteratively until a single variable is left. At each iteration,
we report the performance of the model by using a ten-fold cross-validation, and we pick the
set of features that maximize this value. A summary of this feature selection procedure is pre-
sented in Fig 2. Note that normalization is not needed given that we are using only binary
variables.
Performance evaluation and validation
For all models, we split patients into a training (70%) and test set (30%). We train the models
on the training test, and report performance metrics on the test set (out-of-sample). Fig 2
sketches the full approach employed in this paper. To evaluate the performance of the trained
classifiers we use two metrics: the false alarm (or false positive) rate and the detection rate. The
false alarm rate is the fraction of the patients predicted to be in the positive class while they
truly were not, among all negative class patients. The term specificity is often used and it equals
Fig 2. Flow diagram describing the general procedure employed in this paper. n is the number of variables available after each step of the pipeline for the
mortality model.
https://doi.org/10.1371/journal.pone.0240346.g002
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1 minus the false alarm rate. In turn, the detection rate measures the number of patients pre-
dicted to be in the positive class while they truly were, divided by all positive class patients. In
the medical literature, the detection rate is often referred to as sensitivity or recall. A single
metric that encapsulates these errors is the Area Under the Curve (AUC) of the Receiver Oper-
ating Characteristic (ROC). The ROC plots the detection rate over the false positive rate. A
blind random selection (assigning patients to classes randomly) has AUC of 0.5 while a perfect
classifier an AUC of 1. In addition to the AUC, we report the accuracy of the classifier which
calculates the ratio between the number of correct classifications over the total number of pre-
dictions. Moreover, we report the weighted F1-score to summarize the precision and recall for
both the positive class and the negative class. The weighted F1-score (F1w) computes the
weighted average (using the number of samples per class) of the harmonic mean of precision
and recall per class. This metric is of interest to this work because it is as important to accu-
rately predict who is likely to, or not to, have a specific outcome. For example, one can lessen
physical distancing restrictions based on those who are predicted to have lower risk.
Results
We train two classifiers using 70% of the observations to predict (1) mortality and (2) need for
a mechanical ventilator for a COVID-19 patient based on demographics, comorbidities, symp-
toms, and some clinical information (e.g., x-ray findings). For each model, we compare the
performance of five different predictors, which include interpretable and non-interpretable
state-of-the-art classifiers. Our results suggest that LR and SVM achieve comparable perfor-
mance to the non-interpretable methods, as can be seen in Tables 2 and 3, and provide insights
about how different features affect the outcome. Observe that the more complicated methods,
RF and XGBoost, do not provide any improvement in performance compared with LR for
both tasks.
As mentioned earlier, interpretability is desired in this application to identify the main vari-
ables used to classify an individual as high (or low) risk. This information can be obtained
through the coefficients of the LR model, the odds ratio (OR) and the corresponding confi-
dence intervals (CI) obtained for each variable. Specifically, the Odds Ratio (OR) indicates
how the odds of observing the outcome are scaled when the variable takes the value 1 (vs. 0),
while controlling for all other variables in the model. Once we identify the features to be used
from our feature selection procedure, we use ℓ2-regularized LR to compute the coefficients,
ORs, and the corresponding confidence intervals.
Table 2. Mortality results.
SVM-l1 LR-l1 LR-l2 RF XGBoost
Accuracy 0.720 0.719 0.718 0.713 0.719
F1w 0.721 0.720 0.719 0.714 0.719
AUC 0.790 0.790 0.790 0.786 0.792
https://doi.org/10.1371/journal.pone.0240346.t002
Table 3. Ventilator results.
SVM-l1 LR-l1 LR-l2 RF XGBoost
Accuracy 0.764 0.766 0.766 0.763 0.761
F1w 0.746 0.746 0.745 0.747 0.745
AUC 0.694 0.694 0.694 0.695 0.695
https://doi.org/10.1371/journal.pone.0240346.t003
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Some of the main features that predict mortality and the need for a mechanical ventilator
are related with socioeconomic characteristics rather than with prior medical conditions or
symptoms (see Table 4 and Figs 3 and 4), which can motivate further investigation in this
direction. We observe that for predicting mortality, geographic location of the hospital (North-
east OR = 2.2, North OR = 2.0, Midwest OR = 0.8, South OR = 0.6), education level (No educa-
tion OR = 1.1, Elementary 1-5 OR = 1.0, Medium 1-3 OR = 0.9, Superior OR = 0.6), hospital
type (Public OR = 1.24, Private OR = 0.65), and race (Indigenous OR = 1.2, Yellow OR = 1.2,
White OR = 0.9) are key variables for classifying the outcome of a patient. Furthermore, to pre-
dict the need for mechanical ventilation, geographic location (Northeast OR = 0.53, Midwest
OR = 0.45, South OR = 0.33, Southeast OR = 0.33) and education level (Medium 1-3
OR = 0.77, Superior OR = 0.71) are relevant variables. From a clinical perspective, the results
of the coefficients are consistent with recent studies highlighting the importance of variables
such as age, chronic renal insufficiency, hypoxia, diabetes, and obesity. Figs 3 and 4 depict the
ORs with their confidence intervals for the mortality and ventilator models respectively.
In addition to these two models, we train more advanced models for predicting the events
of interest. These advanced models are provided with more information about the evolution of
the disease. For mortality, we include information on whether a patient is in an ICU and on a
ventilator. When these data is provided, the accuracy and AUC of the model increases by 6.8%
and 8.0%, respectively, compared to the ones presented in Table 2 and Fig 3. Conversely, for
the advanced ventilation model, we include the variable ICU which improves the accuracy and
AUC of the model by 8.7% and 24.6% respectively. The specific results of these models are pro-
vided in the S1 File of this manuscript.
Discussion
We generated moderately to significantly accurate predictive models of mortality and ventila-
tor use for COVID-19 patients that are sparse and interpretable based only on demographics,
symptoms, comorbidities, and socieconomic variables. Our results confirm previously
described clinical presentations and outcomes of COVID-19-related hospital admissions, but
also suggest that additional non-clinical features, in particular sociodemographic information,
are important explanatory variables. The following comorbidities were found to be highly pre-
dictive of mortality: renal (OR = 2.0) and liver chronic disease (OR = 1.7), immunosuppression
(OR = 1.7), obesity (OR = 1.7), chronic pneumopathy (OR = 1.4), neurological (OR = 1.6),
hematologic (OR = 1.2) and cardiovascular (OR = 1.1) disease, diabetes (OR = 1.4), and immu-
nosuppression (OR = 1.3). Respiratory symptoms, ranging from respiratory discomfort
(OR = 1.4) and dyspnea (OR = 1.32) to oxygen saturation less than 95% (OR = 1.7), were also
significantly associated with mortality risk among COVID-19 patients. Of note, cardiovascular
disease includes hypertension, history of myocardial infarction, stroke, congestive heart fail-
ure, and other forms of heart disease. Its low effect on predicting mortality is consistent with
the observations in [32].
Unlike previous studies, we assessed the relationship between socioeconomic factors and
mortality and resource utilization in a low- and middle- income country (LMIC), and found
low patient-reported level of education to be significantly associated with mortality (See
Table 4). We observe that OR for mortality is inversely proportional to self-reported education
level, which is suggestive of disparity on health outcomes for different population subgroups.
A 2017 census revealed that 7% of the population aged 15 years or older in Brazil was illiterate
[33]; this corresponds to approximately 11.5 million inhabitants. In addition to education, we
found that geographic location of the hospital in which a COVID-19 patient was admitted was
also a strong predictor of outcome. Based on postal code, we mapped hospital location to one
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Table 4. Mortality coefficients for ℓ2-LR.
β CI (2.5) CI (97.5) OR CI (2.5) CI (97.5)
Age 0-30 -1.988 -2.413 -1.562 0.137 0.090 0.210
Age 30-50 -1.426 -1.843 -1.008 0.240 0.158 0.365
Region_Northeast 0.782 0.362 1.201 2.185 1.436 3.325
Region_North 0.723 0.302 1.144 2.061 1.352 3.140
Age 50-65 -0.712 -1.129 -0.295 0.491 0.323 0.745
Renal Chronic Disease 0.694 0.611 0.776 2.001 1.842 2.173
Contracted At Hospital 0.591 0.477 0.704 1.805 1.612 2.023
Liver Chronic Disease 0.540 0.366 0.714 1.716 1.442 2.041
Immunosuppression 0.511 0.413 0.609 1.667 1.512 1.838
Obesity 0.510 0.421 0.598 1.665 1.524 1.819
SpO2 less 95% 0.504 0.466 0.543 1.656 1.594 1.721
Neurological Disease 0.496 0.410 0.582 1.642 1.507 1.790
Cough -0.485 -0.527 -0.443 0.616 0.590 0.642
Region_South -0.481 -0.909 -0.054 0.618 0.403 0.947
Schooling Superior -0.464 -0.551 -0.377 0.629 0.577 0.686
Hospital Private -0.428 -0.470 -0.385 0.652 0.625 0.681
Other Symptoms -0.419 -0.456 -0.381 0.658 0.634 0.683
Down Syndrome 0.388 0.072 0.705 1.475 1.075 2.023
Another Chronic Pneumopathy 0.358 0.270 0.445 1.430 1.310 1.561
Respiratory Discomfort 0.301 0.262 0.339 1.351 1.300 1.404
Dyspnea 0.279 0.238 0.321 1.322 1.268 1.379
Other Risks 0.262 0.223 0.300 1.299 1.250 1.350
Diarrhea -0.257 -0.310 -0.205 0.773 0.733 0.815
Fever -0.249 -0.289 -0.208 0.780 0.749 0.812
Age 65-100 0.244 -0.173 0.660 1.276 0.841 1.936
Asthma -0.229 -0.339 -0.120 0.795 0.713 0.887
Gender_F -0.216 -0.251 -0.181 0.806 0.778 0.834
Hospital Public 0.214 0.171 0.257 1.239 1.187 1.293
Diabetes 0.198 0.159 0.238 1.219 1.172 1.269
Throat -0.191 -0.236 -0.145 0.827 0.790 0.865
Region_Midwest -0.178 -0.608 0.252 0.837 0.545 1.286
Hematologic Disease 0.173 -0.002 0.348 1.188 0.998 1.416
Race Indigenous 0.167 -0.139 0.472 1.181 0.871 1.603
Schooling Medium 1-3 -0.154 -0.213 -0.095 0.858 0.808 0.910
Race Yellow 0.145 -0.022 0.312 1.156 0.978 1.366
Cardiovascular Disease 0.113 0.075 0.151 1.120 1.078 1.163
Xray Thorax Result Consolidation 0.105 0.004 0.206 1.111 1.004 1.229
Acute Respiratory Distress Syndrome 0.075 0.035 0.114 1.078 1.036 1.121
Postpartum 0.067 -0.258 0.391 1.069 0.773 1.479
Schooling No Education 0.064 -0.049 0.178 1.066 0.952 1.194
Race White -0.062 -0.104 -0.020 0.940 0.902 0.980
Vomiting -0.055 -0.123 0.012 0.946 0.885 1.012
Region_Southeast 0.029 -0.390 0.449 1.030 0.677 1.566
Schooling Elem 1-5 -0.017 -0.078 0.044 0.984 0.925 1.045
https://doi.org/10.1371/journal.pone.0240346.t004
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of five geopolitical regions of Brazil: North, Northeast, Midwest, Southeast, and South.
Although these regions are officially recognized, this division has no political effect other that
guiding the development of federal public policies. Currently, patterns of economic activity
and population settlement vary widely among the regions, as do development indices. The
average Human Development Index (HDI) in North and Northeastern regions is significantly
lower than the national average (0.66 in both regions vs. 0.76 nationwide), as are the literacy
rates. In this context, it is revealing that the odds of mortality to COVID-19 were significantly
higher for patients hospitalized in the North and Northeast regions.
The Unified Health System (Sistema Único de Saúde—SUS), Brazil’s publicly funded health
care system, was created by a constitutional act in 1989. It represents the only source of medi-
cal care for approximately 75% of the population [34], 80% of which are of self-reported black
race [35]. Although Brazil has a mixed delivery system of public and private hospitals, only
24.2% of the population has private insurance [36]. As in many LMICs, SUS is underfunded
and overstretched, and resource availability in public health care institutions is limited in
Fig 3. Odds ratios and confidence intervals for the ℓ2−LR mortality model.
https://doi.org/10.1371/journal.pone.0240346.g003
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comparison with their private counterparts [37]. In contrast, large public hospitals serve as the
entry point into the health care system for many severe and/or urgent patients, including those
who have access to private insurance and are frequently transferred to private hospitals follow-
ing initial assessment. Interestingly, our results indicate that COVID-19 patients hospitalized
in public hospitals have higher risk of mortality, irrespective of the geographic location of the
hospital (as we are controlling for this variable).
Taken together, our results highlight the predictive power of socioeconomic information in
assessing COVID-19 mortality. From a practical perspective, our findings suggest that deci-
sions on medical resource allocation throughout the COVID-19 pandemic could be guided by
local patterns of patient demographics within a LMIC. Moreover, our study suggests that the
definition of vulnerable subgroups, for the purposes of targeted policy design, encompasses
not only individual patient features (such as race and education level), but also an understand-
ing of the structure of the health care system by which these patients are served.
Fig 4. Odds ratios and confidence intervals for the ℓ2−LR ventilator model.
https://doi.org/10.1371/journal.pone.0240346.g004
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Study limitations
First, we do not claim our results to provide a complete causal-effect analysis, as this task
requires a more sophisticated analysis. However, we do think that given all the controls in our
models, these results shed light and motivate further investigations of social disparities in
health care access in LMICs. Second, from a clinical point of view, it is relevant to highlight
that the dataset lacks important information (such as lab results) to provide a clinical assess-
ment of COVID-19. Such information is hard to obtain at the scale we consider. Rather, the
focus of this work is to open the discussion about socioeconomic disparities in health access,
as well as to help inform decisions on how to best allocate limited medical resources and
design targeted policies for vulnerable subgroups which might not have access to clinical and
lab assessments. Third, we note that the dataset might be biased towards assessing the risk of
high-risk patients given that we are observing only COVID-19 cases which have been hospital-
ized. for this study dataset does not include specific dates at which hospitals discharge patients,
which is of high importance to assess the utilization of medical equipment. to prioritize the use
of resources, we understand that medical risk is not the only factor in making such decisions.
Nevertheless, in order to quantify medical risk one can leverage the models presented in this
work.
Conclusions
Classifying the medical risk of COVID-19 patients is relevant for low- and medium- income
countries in order to assign limited medical resources more effectively, as well as to help design
targeted physical-distancing and work accommodation policies that will assist in reducing eco-
nomic loss during the current pandemic. In the future, this model could help prioritize vaccine
distribution to the more risk-vulnerable and to those who need to interact with them.
To facilitate further work, and for the sake of reproducibility, our models and results are
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